Forward Citations = 1

Loading Chart...

1 inventor (with patents filed for the assignee):

Kathleen E Clarence-Smith (4 out of 35 patents)

4 patents: Sort by Forward Citations

1. 11896582 - Use and composition for treating myasthenia gravis and other myasthenic syndromes (2024-02-13),

2. 11752141 - Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis (2023-09-12),

3. 11389420 - Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis (2022-07-19),

4. 10842778 - Use and composition for treating myasthenia gravis and other myasthenic syndromes (2020-11-24),

Company Overview

Das-mg, Inc. is a leading provider of strategic management consulting services. We specialize in helping businesses improve their operations, optimize their strategies, and achieve their goals. Our team of experts works closely with clients to develop tailored solutions that drive success and growth. With a focus on innovation and excellence, we are committed to delivering real, measurable results for our clients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#342 in Boston, MA

#3,313 in Massachusetts

#60,641 in US

Boston, MA, United States of America

Das-Mg, Inc.

Forward Citations = 1

1 inventor:

Kathleen E Clarence-Smith (4 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Das-Mg, Inc.. Retrieved from https://idiyas.com/company/das-mg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]